We have collected information about Fluticasone Propionate Liposomes For Pulmonary Delivery for you. Follow the links to find out details on Fluticasone Propionate Liposomes For Pulmonary Delivery.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846484/
The spray dried liposomes were further characterized for various physicochemical properties such as physical appearance, density, flow properties, drug content and in vitro pulmonary deposition. Fine particle fraction was also determined. Liposomal dispersion of fluticasone propionate was successfully prepared with more than 90% entrapment.
http://www.ijpsonline.com/articles/fluticasone-propionate-liposomes-for-pulmonary-delivery.pdf
Fluticasone Propionate Liposomes for Pulmonary Delivery N. M. NIRALE, R. D. VIDHATE AND M. S. NAGARSENKER* Department of Pharmaceutics, Bombay College of Pharmacy, Kalina, Santacruz (East), Mumbai-400 098, India Nirale et al.: Fluticasone Propionate LiposomesAuthor: AV Bhalerao, SL Lonkar, SS Deshkar, SV Shirolkar, AD Deshp
http://europepmc.org/articles/PMC2846484
The spray dried liposomes were further characterized for various physicochemical properties such as physical appearance, density, flow properties, drug content and in vitro pulmonary deposition. Fine particle fraction was also determined. Liposomal dispersion of fluticasone propionate was successfully prepared with more than 90% entrapment.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835630/
Oct 10, 2019 · Among GCS, fluticasone propionate (FTZ) is one of the drugs delivered in a dry powder inhaler or by nasal instillation. Nasal and pulmonary delivery routes of administration are non-invasive, convenient, and comfortable, aiming the direct delivery of FTZ to the lungs .Author: Marina G. Dogbe, Ambinintsoa Yattussia Mafilaza, Carla Vânia Eleutério, Helena Cabral-Marques, Sandr...
https://www.researchgate.net/publication/336416134_Pharmaceutical_Benefits_of_Fluticasone_Propionate_Association_to_Delivery_Systems_In_Vitro_and_In_Vivo_Evaluation
Among GCS, fluticasone propionate (FTZ) is one of the drugs delivered in a dry powder inh aler or by nasal instillation. Nasal and pulmonary deli very routes of administration are non-invasive,
https://www.sciencedirect.com/science/article/pii/S0378517316301247
1. Introduction. Drug delivery by inhalation is important for treatment of various pulmonary conditions such as allergy, asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and pulmonary infections as it can administer high drug doses rapidly and directly to the site of disease while minimizing systemic exposure and toxicity associated with oral or intravenous dosing ...Author: Alexey Popov, Lisa Schopf, James Bourassa, Hongming Chen
https://core.ac.uk/display/28525420
Fluticasone propionate liposomes for pulmonary delivery . ... The objective of the present study was to entrap fluticasone propionate in liposomes and study <i>in vitro</i> lung deposition of both liposomal dispersion and dry powder inhalation using twin stage impinger and Anderson cascade impactor. Liposomes were prepared by lipid film ...Author: Nirale N, Vidhate R and Nagarsenker M
https://www.mdpi.com/1999-4923/11/10/521
The objective of the present work was to characterize the ability of liposomes and cyclodextrin (CyD) complexes to modulate the in vivo profile of fluticasone (FTZ). In vitro cell compatibility tests were performed, exposing A549 cells to FTZ in the free form and FTZ associated to liposomes and complexed with CyD. The in vivo fate of a selected FTZ liposomal formulation and of several FTZ CyD ...Author: Marina G. Dogbe, Ambinintsoa Yattussia Mafilaza, Carla Vânia Eleutério, Helena Cabral-Marques, Sandr...
https://www.sciencedirect.com/science/article/pii/S0378517315300272
As nanocarriers offer many advantages over other drug delivery systems, this study investigated the suitability of lipid nanocapsules (LNCs) as a carrier for fluticasone propionate, examining the drug-related factors that should be considered in the formulation design and the behaviour of LNCs with different compositions and properties ...Author: Anita-Monika Umerska, Célia Rosemonde Mouzouvi, André Bigot, Patrick Saulnier
https://www.deepdyve.com/lp/elsevier/formulation-and-nebulization-of-fluticasone-propionate-loaded-lipid-nZ3ZySbE88
Sep 30, 2015 · Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers Inhalation is the preferred route of drug administration for asthma treatment ( Borgström, 2001 ). Pulmonary administration offers many advantages for the treatment of respiratory diseases compared with other routes of delivery.
Searching for Fluticasone Propionate Liposomes For Pulmonary Delivery?
You can just click the links above. The data is collected for you.
